Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...
The Rome V criteria for IBS identified a different group of patients, with lower sensitivity than either Rome III or IV ...
Tresca is a writer and speaker who covers digestive conditions, including IBD. She was diagnosed with ulcerative colitis at age 16. Suzanne Fisher, RD, is a registered dietitian and licensed ...
Researchers at Peter MacCallum Cancer Centre have developed a digital phenotype to assist with automatically identifying ...
Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs for those living with the chronic, unpredictabl ...
AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of children six years of age and older with moderate-to-severe plaque ...
MedPage Today on MSN
Bowel disease, GLP-1s, and colon cancer; herbs for MASLD? Managing bile duct stones
News and commentary from the world of gastroenterology and hepatology ...
Significant advances in ulcerative colitis care prompted an update to the American College of Gastroenterology (ACG) guideline for moderately to severely active disease in adults. In recent years, a ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
bDepartment of Epidemiology and Biostatistics, Western University, London, ON, Canada cDepartment of Medicine, Division of Gastroenterology, Western University, London, ON, Canada Despite an expanding ...
Disease clearance is the simultaneous achievement of symptomatic, endoscopic and histologic remission. In real-world studies, achieving disease clearance has been associated with reduced rates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results